Acrivon Therapeutics, Inc. — S-8 Filings
7 S-8 filings on record
This page lists all S-8 filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 7 S-8 documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001193125-26-115150 | Mar 19, 2026 | — |
| S-8 | S-8 | 0001193125-25-119914 | May 14, 2025 | — |
| S-8 | S-8 | 0001193125-25-066369 | Mar 28, 2025 | — |
| S-8 | S-8 | 0001193125-24-081596 | Mar 29, 2024 | — |
| S-8 | S-8 | 0001193125-23-209859 | Aug 11, 2023 | — |
| S-8 | S-8 | 0001193125-23-082963 | Mar 29, 2023 | — |
| S-8 | S-8 | 0001193125-22-287229 | Nov 17, 2022 | — |